摘要
目的探讨不同剂量沙美特罗替卡松粉吸入剂(ICS/LABA)对大鼠慢性阻塞性肺疾病(COPD)气道重塑的干预作用。方法将40只Wistar大鼠随机分为对照组(A组)、模型组(B组)、低剂量ICS/LABA组(C组)、高剂量ICS/LABA组(D组)。采用烟熏加气管内注射脂多糖(LPS)法复制COPD模型,C、D组吸入中、高剂量ICS/LABA。观察肺功能和病理变化,肺泡灌洗液(BALF)中细胞计数和百分比,图像分析测量小气道平滑肌和管壁厚度,酶联免疫吸附(ELISA)法测定BALF中转化生长因子β1(TGF-β1)的表达,免疫组化法测定肺组织中基质金属蛋白酶9(MMP-9)、分泌性白细胞蛋白酶抑制剂(SLPI)的表达,实时荧光定量聚合酶链式反应(RT-PCR)检测肺组织中MMP-9mRNA的表达。结果 B组肺间质大量炎性细胞浸润,肺泡壁破坏,肺大疱形成,气管管壁和平滑肌增厚,C、D组有所减轻;B组TGF-β1、MMP-9水平与A组大鼠相比明显升高,SLPI则显著降低(P<0.05);干预后C、D组TGF-β1、MMP-9水平与B组相比明显降低,而SLPI则明显升高(P<0.05);D组TGF-β1、MMP-9阳性系数和mRNA相对含量[(82.06±4.43)(2.41±0.22)(6.156±8.86)]显著低于C组[(118.59±5.28)(3.09±0.28)(9.616±10.56)](P<0.05),而SLPI(2.95±0.28)明显高于C组(2.11±0.26)(P<0.05)。结论 ICS/LABA对COPD大鼠肺泡破坏及气道重塑有抑制作用,且高剂量优于低剂量,其机制可能与降低TGF-β1和MMP-9的表达及提高SLPI的水平有关。
Objective To evaluate the effect of different doses of salmeterol/ fluticasone(LABA/ ICS) inhalant on the air-way remodeling of chronic obstructive pulmonary disease (COPD) in rats and its possible mechanism. Methods Forty Wistarrats were divided into four groups:the control (group A), the model (group B), the low dose of LABA/ ICS (groups C), and thehigh dose of LABA/ ICS (group D). Rats were exposed to cigarette smoking daily and intratracheal instillation of lipopolysaccharide (LPS)twice daily to establish the COPD model. LABA/ ICS was inhaled to the rats of COPD models for 30 days in groups of C andD. The pathological changes in lung were observed and spirometry function was detected. The expression of TGF-茁1 in BALF wastested by ELISA. The expression of MMP-9 and SLPI in lung was determined by immunohistochemistry. The expression of MMP-9mRNA in bronchi and lung was assessed by RT-PCR. Results The inflammatory cells infiltration, alveolar wall damage, bullaeformation in lung and thickening of trachea wall and smooth muscle were found in group B, but less obvious in group C and D. Com-pared to group A, group B had higher expression of MMP-9 and TGF-β1 level,but lower SLPI (P〈0. 05). After intervention withICS/ LABA,both MMP-9 mRNA expression and TGF-β1 level were dramatically decreased,but SLPI was increased in group C and Dcompared with group B(P〈0. 05 ). The TGF-β1 , MMP-9 and its mRNA in group D[(82.06±4. 43), (2. 41±0. 22), (6. 156±8.86)]were lower than group C[(118. 59±5. 28), (3. 09±0. 28), (9. 616±10.56)], the SLPI(2. 95±0. 28) was much higherthan group C(2.11±0.26). Conclusion ICS/ LABA inhibits the airway wall remodeling of the COPD rats in a dose-dependentmanner, which may be associated with upregulation of TGF-β1 and MMP-9 expression and elevation of SLPI.
出处
《医药导报》
CAS
北大核心
2014年第3期318-322,共5页
Herald of Medicine